NCT00197132View on ClinicalTrials.gov

Study In Patients With Insulin Resistance

PHASE3CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Insulin Resistance

Interventions

DRUG

Avandia

Trial Locations (1)

6525EZ

GSK Clinical Trials Call Center, Nijmegen

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY